(3513056), R. S., (8854754), R. Z. T., (5396393), V. S. N., (7397276), N. M. A., & (5396390), E. E. (2019). PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer.
Chicago Style (17th ed.) Citation(3513056), Reem Saleh, Rowaida Z. Taha (8854754), Varun Sasidharan Nair (5396393), Nehad M. Alajez (7397276), and Eyad Elkord (5396390). PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. 2019.
MLA (9th ed.) Citation(3513056), Reem Saleh, et al. PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. 2019.